Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2135.79 (Glytoucan)

Id:06a5a368-c9f4-5b47-8805-109b82a07780

Glytoucan:G11107QZ

Results found

Linked to

	Label	Description
	2135.79 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G39204IU-GLYCOSEQ00149983 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G26844MI-GLYCOSEQ00003013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G85891RL-GLYCOSEQ00151153 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has canonical residue n-glycan b-d-glcpnac 11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G35642GA-GLYCOSEQ00162415 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G02625OQ-GLYCOSEQ00118178 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has canonical residue n-glycan a-l-fucp 41 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G95273QR-GLYCOSEQ00049094 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G55650NN-GLYCOSEQ00096549 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G39204IU-GLYCOSEQ00149983 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G26844MI-GLYCOSEQ00003013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G85891RL-GLYCOSEQ00151153 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has canonical residue n-glycan b-d-glcpnac 11

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G35642GA-GLYCOSEQ00162415 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G02625OQ-GLYCOSEQ00118178 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has canonical residue n-glycan a-l-fucp 41

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G95273QR-GLYCOSEQ00049094 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2135.79 has glycosequence GLYGEN.GLYCOSEQUENCE:G55650NN-GLYCOSEQ00096549 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.